United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Universe Pharmaceuticals INC? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -23.76% | -31.42% | -49.5% | -98.27% | -213.8% | -365.6% |
|---|---|---|---|---|---|---|
| ROA | -15.91% | -17.74% | -17.98% | -19.14% | -19.75% | -20.05% |
| Gross Margin | 26.37% | 15% | 15% | 15% | 15% | 15% |
| Net Margin | -37.9% | -46.81% | -45.23% | -45.94% | -46.49% | -46.35% |
| Total Assets | $67,953.39K | $71,322.70K | $74,990.85K | $78,984.66K | $83,333.41K | $88,068.08K |
| Net Income | -$8,727.30K | -$12,355.93K | -$13,152.55K | -$14,735.74K | -$16,030.61K | -$17,186.90K |